ADC Therapeutics

ADCT

Börsenwert 197 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Redmile Group San Francisco, California	30,2 Mio. $	+1,09 Mio. $	+484.686	+4 %
2	2 Prosight Management Dallas, Texas	12 Mio. $	+5,23 Mio. $	+2.326.540	+71 %
3	3 Sio Capital Management New York	8,64 Mio. $	+4,18 Mio. $	+1.860.073	+86 %
4	4 Citadel Advisors Miami, Florida	6,82 Mio. $	-442.609 $	-196.855	-6 %
5	5 JP Morgan Chase New York	5,93 Mio. $	-745.868 $	-331.733	-11 %
6	6 Bank of America Charlotte, North Carolina	3,58 Mio. $	+49.249 $	+21.904	+1 %
7	7 Frazier Life Sciences Management Palo Alto, California	3,54 Mio. $	–	–	–
8	8 Millennium Management New York	3,06 Mio. $	-829.756 $	-369.043	-21 %
9	9 Pictet Asset Management (Switzerland) Geneva 73, Switzerland	2,73 Mio. $	-217.099 $	-96.557	-7 %
10	10 T. Rowe Price Associates Baltimore, Maryland	2,63 Mio. $	-190.215 $	-84.600	-6 %
11	11 Goldman Sachs New York	2,45 Mio. $	-2,73 Mio. $	-1.216.116	-52 %
12	12 Vantage Consulting Group Virginia Beach, Virginia	1,9 Mio. $	-676.083 $	-300.695	-25 %
13	13 Nantahala Capital Management New Canaan, Connecticut	1,81 Mio. $	–	–	–
14	14 AlphaCentric Advisors San Juan, Puerto Rico	1,67 Mio. $	+40.471 $	+18.000	+2 %
15	15 Blue Owl Capital Holdings New York	1,58 Mio. $	–	–	–
16	16 Morgan Stanley New York	1,4 Mio. $	+483.022 $	+214.829	+49 %
17	17 Affinity Asset Advisors New York	1,29 Mio. $	–	–	–
18	18 BlackRock New York	1,01 Mio. $	-375.577 $	-167.042	-26 %
19	19 GCM Grosvenor Holdings Chicago, Illinois	883.409 $	–	–	–
20	20 Marshall Wace London, United Kingdom	784.875 $	+466.271 $	+207.379	+132 %
21	21 Barclays London, United Kingdom	677.089 $	-43.500 $	-19.347	-6 %
22	22 XTX Topco George Town, Cayman Islands	443.689 $	-134.661 $	-59.892	-22 %
23	23 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	315.117 $	–	–	–
24	24 Laurion Capital Management New York	259.894 $	+271.789 $	+120.881	Neu
25	25 GSA Capital Partners London, United Kingdom	234.000 $	+191.647 $	+85.237	+360 %

ADC Therapeutics ADCT Börsenwert 197 Mio. $

ADC Therapeutics

ADCT

Börsenwert 197 Mio. $